Addressing Disparities in Cancer Care for Latino Medicare Beneficiaries

NCT ID: NCT00385866

Last Updated: 2016-04-20

Study Results

Results pending

The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.

Basic Information

Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.

Recruitment Status

COMPLETED

Clinical Phase

NA

Total Enrollment

1272 participants

Study Classification

INTERVENTIONAL

Study Start Date

2006-10-31

Study Completion Date

2010-12-31

Brief Summary

Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.

To reduce Cancer health care disparities that exists among minority Medicare beneficiaries and to demonstrate cost effectiveness of patient navigation in reducing the burden of cancer.

Detailed Description

Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.

The Latino population is the fastest growing minority population in the United States . Cancer ranks as the second leading cause of death among Latinos in the United States (24%), second only to heart disease . This project will evaluate whether an innovative facilitation program (targeting cancers of the prostate, colon/rectum, breast, and cervix) will improve cancer outcomes among Latino Medicare beneficiaries in the city of Newark, New Jersey.

The overall aim of this project is to institute an innovative cancer care facilitation program for elderly Latinos in the city of Newark, NJ. The goal is to reduce the disparities observed in screening, time to diagnosis and treatment services, by utilizing a multidisciplinary team approach to health care, incorporating systems thinking methodology. Using the Multilevel Approach to Community Health (MATCH) planning model , the program will incorporate community outreach, education, and access to screening, and patient assistance in all aspects of the health care continuum. It will also include cultural and linguistic competency training for all those involved in the facilitation process. To accomplish this goal, we propose four objectives:

1. To establish a multidisciplinary team that will utilize a systems thinking approach to design and structure the delivery of cancer screening, diagnosis and treatment facilitation services.
2. To build a collaborative consortium between program partners to improve screening outcomes, that will encourage the utilization of services in the community.
3. To improve the delivery of cancer prevention and treatment facilitation by providing cultural and linguistic competency training to the multidisciplinary team, providers, and the community.
4. To demonstrate the effectiveness of the intervention in reducing the burden of cancer, by increasing screening rates, improving time to diagnosis and delivery of treatment services, patient satisfaction, and appropriate use of Medicare services.

Conditions

See the medical conditions and disease areas that this research is targeting or investigating.

Cancer

Study Design

Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.

Allocation Method

RANDOMIZED

Intervention Model

PARALLEL

Primary Study Purpose

PREVENTION

Blinding Strategy

NONE

Study Groups

Review each arm or cohort in the study, along with the interventions and objectives associated with them.

Comparison Group

The control or lesser intervention group, will receive cancer screening information on a quarterly basis, with no facilitation of services.

Group Type ACTIVE_COMPARATOR

cancer screening and health education

Intervention Type BEHAVIORAL

The control group will receive cancer screening and health education materials on a quarterly basis but will not have access to patient navigation services.

Intervention group

The intervention group are those participants who were randomly assigned to receive facilitation of services in the form of patient navigation for the duration of the study.

Group Type ACTIVE_COMPARATOR

cancer screening and health education

Intervention Type BEHAVIORAL

The control group will receive cancer screening and health education materials on a quarterly basis but will not have access to patient navigation services.

facilitation of Services to improve cancer screening

Intervention Type BEHAVIORAL

The intervention group will receive cancer education and faciliation of services in the form of patient navigation

Interventions

Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.

cancer screening and health education

The control group will receive cancer screening and health education materials on a quarterly basis but will not have access to patient navigation services.

Intervention Type BEHAVIORAL

facilitation of Services to improve cancer screening

The intervention group will receive cancer education and faciliation of services in the form of patient navigation

Intervention Type BEHAVIORAL

Other Intervention Names

Discover alternative or legacy names that may be used to describe the listed interventions across different sources.

patient navigation cancer screening and education patient navigation faciliation of services screening

Eligibility Criteria

Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.

Inclusion Criteria

Cancer-Negative Group

1. Be of Hispanic/Latino Origin
2. Fluent in English and/or Spanish
3. Recipient of, Medicare Part A \& B, or combined Medicare/Medicaid
4. Not having a previous diagnosis of cancer
5. Be capable of giving written informed consent prior to any study related procedures.
6. Be available and willing to complete all study assessments as specified.

Cancer-Positive Group

1. Be of Hispanic/Latino Origin
2. Fluent in English and/or Spanish
3. Recipient of, Medicare Part A \& B, or combined Medicare/Medicaid
4. Having a previous diagnosis of cancer of the breast, cervix, colon and/or rectum, prostate, or lung.
5. Be capable of giving written informed consent prior to any study related procedures.
6. Be available and willing to complete all study assessments as specified.

Exclusion Criteria

1. Member of the Medicare Advantage Plan, any Medicare managed care plan (Those who join the Medicare Advantage plan or a managed care plan during the course of the study will become ineligible to continue.)
2. Medicaid only beneficiaries
3. Institutionalized
4. Unable to provide written informed consent
Eligible Sex

ALL

Accepts Healthy Volunteers

Yes

Sponsors

Meet the organizations funding or collaborating on the study and learn about their roles.

Centers for Medicare and Medicaid Services

FED

Sponsor Role collaborator

University of Medicine and Dentistry of New Jersey

OTHER

Sponsor Role lead

Responsible Party

Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.

Responsibility Role SPONSOR

Principal Investigators

Learn about the lead researchers overseeing the trial and their institutional affiliations.

Ana Natale-Pereira, MD, MPH

Role: PRINCIPAL_INVESTIGATOR

Rutgers, The State University of New Jersey

Locations

Explore where the study is taking place and check the recruitment status at each participating site.

UMDNJ

Newark, New Jersey, United States

Site Status

Countries

Review the countries where the study has at least one active or historical site.

United States

Other Identifiers

Review additional registry numbers or institutional identifiers associated with this trial.

0120060236

Identifier Type: -

Identifier Source: org_study_id

More Related Trials

Additional clinical trials that may be relevant based on similarity analysis.

Breast Cancer Prevention Education
NCT01299623 COMPLETED NA